Psychiatry
Behavioral Activation Contributed to the Total Reduction of Depression Symptoms in the Smartphone-based Cognitive Behavioral Therapy: A Secondary Analysis of a Randomized, Controlled Trial
by Hissei Imai, MD, PhD; Mitsuhiko Yamada, MD, PhD; Masatoshi Inagaki, MD, PhD; Norio Watanabe, MD, PhD; Bun Chino, MD, PhD; Akio Mantani, MD, PhD; and Toshiaki A Furukawa, MD, PhD Drs. Imai, Watanabe, and Furukawa are with the Department of Health Promotion of Human Behavior at Kyoto University Graduate School of Medicine / School […]
The Depression Inventory Development Scale: Assessment of Psychometric Properties Using Classical and Modern Measurement Theory in a CAN-BIND Trial
by Anthony L. Vaccarino, PhD; Amir H. Kalali, MD; Pierre Blier, MD, PhD; Susan Gilbert Evans, MSc; Nina Engelhardt, PhD; Jane A. Foster, PhD; Benicio N. Frey, MD, PhD; John H. Greist, MD; Kenneth A. Kobak, PhD; Raymond W. Lam, MD, FRCPC; Glenda MacQueen, MD, PhD, FRCPC; Roumen Milev, MD, PhD, FRCPsych, FRCPC; Daniel J. […]
Role of Norepinephrine in Schizophrenia: An Old-fashioned but New Story from Emergency Medicine
Dear Editor: A number of hypotheses have been put forth regarding the etiology of schizophrenia, including dopamine hypothesis and glutamate hypothesis.1 However, a lesser known theory is that elevated norepinephrinergic signaling plays a causative role in schizophrenia.2 We treated a patient with septic shock schizophrenia who developed delusions and hallucinations following continuous norepinephrine infusion. This […]
How the COVID-19 Pandemic is Changing Mental Health Disease Management: The Growing Need of Telecounseling in Italy
Continue Reading